Showing results (691-700 of 711) with videos related to
Sort By:
Pageof 72
Transplantation|November 15, 1996
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppressionR Shapiro, C Vivas, V P Scantlebury, et al.The Annals of Thoracic Surgery|March 29, 2000
Effects of donor bone marrow infusion in clinical lung transplantationS M Pham, A S Rao, A Zeevi, et al.Transplantation|January 27, 1997
Tacrolimus rescue therapy for renal allograft rejection--five-year experienceM L Jordan, R Naraghi, R Shapiro, et al.The American Journal of Surgical Pathology|April 24, 2004
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesisA J Demetris, B Eghtesad, A Marcos, et al.Hepatology (Baltimore, Md.)|March 1, 1997
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver diseaseP Ricci, T M Therneau, M Malinchoc, et al.Transplantation|December 27, 1996
Tacrolimus in pediatric renal transplantationR Shapiro, V P Scantlebury, M L Jordan, et al.The Journal of Urology|November 17, 1998
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first reportR Shapiro, M L Jordan, V P Scantlebury, et al.Transplantation Proceedings|April 9, 1998
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patientsR J Corry, M F Egidi, R Shapiro, et al.Journal of the American College of Surgeons|May 16, 1998
Clinical intestinal transplantation: new perspectives and immunologic considerationsK Abu-Elmagd, J Reyes, S Todo, et al.Transplantation|February 25, 1999
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipientsR Shapiro, M L Jordan, V P Scantlebury, et al.Pageof 72